In T2D, BDNF has been described to have metabolic effects in peripheral tissues (liver, muscle, adipose tissues, and pancreas) and could participate in insulin sensitivity improvement through a reduction in food intake, the prevention of pancreas cell death, or by decreasing glucose and insulin levels [86,87]. This evidence concerns the gene INS and type 2 diabetes mellitus.